Litcius/Paper detail

Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy

Thiago Aparecido da Silva, Paul Hauser, Irfan Bandey, Tamara Laskowski, Qi Wang, Amer Najjar, Pappanaicken R. Kumaresan

2020Cytotherapy36 citationsDOIOpen Access PDF

Topics & Concepts

Cryptococcus neoformansCryptococcosisCryptococcus gattiiBiologyCryptococcusMicrobiologyPopulationImmune systemImmunologyVirologyMedicineEnvironmental healthFungal Infections and StudiesCAR-T cell therapy researchAntifungal resistance and susceptibility
Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy | Litcius